Ponatinib efficacy and safety in patients with the T315I mutation: Long-term follow-up of phase 1 and phase 2 (PACE) trials Meeting Abstract


Authors: Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Baccarani, M.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; Flinn, I.; Lustgarten, S.; Rivera, V. M.; Haluska, F. G.; Clackson, T.; Talpaz, M.
Abstract Title: Ponatinib efficacy and safety in patients with the T315I mutation: Long-term follow-up of phase 1 and phase 2 (PACE) trials
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242705203
PROVIDER: wos
DOI: 10.1182/blood.V124.21.4552.4552
Notes: Meeting Abstract: 4552 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    275 Mauro